Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. GLP-1

GLP-1

  • Diabetes (716)
    • Blood Glucose Meters (12)
    • Complications (120)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (79)
    • Drug-Induced Hypo/Hyperglycemia (103)
    • Monitoring (99)
    • Natural Medicines/Supplements (12)
    • Prevention (32)
    • Treatment (282)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (16)
      • Bromocriptine (5)
      • Combination Products (20)
      • Gliptins (66)
      • Glitazones (95)
      • GLP-1 (29)
      • Incretin Enhancers/Mimetics (59)
      • Insulin (165)
      • Meglitinides (37)
      • Metformin (102)
      • SGLT2 Inhibitors (52)
      • Sulfonylureas (98)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (7)
  • Hyperglycemia (34)
  • Hypoglycemia (16)
  • Other (20)
  • Prediabetes (2)
  • Resources (165)
  • Thyroid Disorders (60)
1 - 15 of 29 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Drugs for Type 2 Diabetes
August 2023
Chart: How to Switch Insulin Products May 2023
Article: Don’t Expect to Always See Metformin First for Type 2 Diabetes February 2023
Toolbox: Improving Diabetes Outcomes February 2023
Chart: Diabetes Medications: Cardiovascular and Kidney Impact September 2022
Chart: Comparison of Insulins (Canada) September 2022
Technician Tutorial: Dispensing Insulin and Other Injectable Diabetes Meds August 2022
Article: Watch for Mounjaro, a New Injectable Diabetes Med July 2022
Chart: Guide for Helping Patients Afford Their Medications
October 2021
Article: Think of Rybelsus as the Tablet Version of Injectable Ozempic November 2019
Chart: Comparison of GLP-1 Agonists August 2019
Article: Look Out for Mix-Ups With GLP-1 Agonists for Diabetes August 2019
Article: Know Which Diabetes Meds Help or Worsen Heart Failure March 2019
Technician Tutorial: Diabetes 101 March 2019
Article: Listen for Diabetes Patients Asking About Using Jardiance and Victoza Together July 2018
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved